
The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future
Author(s) -
Carlo Sposito,
Vincenzo Mazzaferro
Publication year - 2018
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2018.10.06
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , liver transplantation , stage (stratigraphy) , liver cancer , cancer , disease , oncology , curative treatment , intensive care medicine , transplantation , paleontology , biology